Učitavanje...
LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectives
Major advances in understanding how genetics underlies Parkinson’s disease (PD) have provided new opportunities for understanding disease pathogenesis and potential new targets for therapeutic intervention. One such target is leucine-rich repeat kinase 2 (LRRK2), an enigmatic enzyme implicated in bo...
Spremljeno u:
| Izdano u: | Clin Pharmacol |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5076802/ https://ncbi.nlm.nih.gov/pubmed/27799832 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CPAA.S102191 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|